German Chancellor Angela Merkel does not consider the cancellation of patents for them to be a solution to the problem of providing coronavirus vaccines.
The evaluation of the effectiveness of the waiver of intellectual property rights for coronavirus vaccines was previously carried out by the team of US Trade Representative Katherine Tai.
She noted that “the market is not yet able to meet the health needs of developing countries.”
Last Thursday, the Bundestag voted against a proposal to cancel patents for these drugs.
“I do not believe that the suspension of patents is a solution that will provide more people with vaccines. However, I believe that we need the ingenuity and innovative potential of companies, and, in my opinion, this also includes the protection of patents,” Merkel said.
According to her, issuing licenses for the production of vaccines will help provide them to more people, while “patent holders must monitor the quality of products.”